Institutional investors purchased a net $1.2 million shares of RMD during the quarter ended December 2016 and now own 64.87% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 2.4 Million shares of ResMed Inc
NORGES BANK INVESTMENT MANAGEMEN... Bought 502.1 Thousand shares of ResMed Inc
RUSSELL INVESTMENT MANAGEMENT LL... Bought 388.0 Thousand shares of ResMed Inc